Thursday , December 2 2021

Tag Archives: aurangabad

FDC receives EIR for Aurangabad facility

FDC has received an Establishment Inspection Report (EIR) for its manufacturing facility located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which was inspected from August 10, 2018 to August 16, 2018 by US Food and Drug Administration (USFDA). The facility is considered to be acceptable with regards to current ... Read More »